DOCSLIB.ORG

Part 2. Proteins

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Part 2. Proteins Proteins Part 2. Proteins White & White — Proteins, Peptides & Amino Acids SourceBook 5 Proteins 4-IBBL Acid Glycoprotein VI, α1- PeproTech 310-11 Human recombinant, expressed in E. coli Synonyms: Orosomucoid MW 19.5k >98% (SDS-PAGE) & HPLC; <0.1 ng endotoxin per Fluka 50646 Human plasma MW 45k ≥98% (GE); 60% mg (1EU/mg); lyophilized | Member of the emerging family of protein; 6% water | Arnaud, P et al, Meth Enzymol, 163: 418, ligands with structural homology to tumor necrosis factor; 185 AA; 1988; Eap, CB & Baumann, P, Electrophoresis, 9: 650, 1988 ED50 < 10ng/mL; SA determined by the dose-dependent stimulation of IL-8 production by human PBMC Acid Glycoprotein, α1- α 6CKINE Synonyms: Orosomucoid; Seromucoid, 1- Synonyms: Exodus II; SLC; T-Cell Activation Gene IV Fluka 50647 Bovine serum ≥99% (gel electrophoresis); ≤5% Biodesign A52013M E. coli Purified | Species specificity: water; ~70% protein mouse Biodesign A50106H Human Purified Biodesign A52035H E. coli Purified Fitzgerald 30-AA01 Human plasma High purity | Chemicon GF086 Human ≥95% Orosomucoid ICN 153905 Human plasma MW 44.1k Lyophilized, salt Biogenesis 4396-0150 Human r-DNA Lyophilized free, >99% BioSource International PHC1474 Human recombinant ICN 191348 Human plasma MW 44.1k Lyophilized, salt PeproTech 300-35 Human recombinant, expressed in E. coli free, >99% (SDS-PAGE) | Negative for HBs Ag & HIV antibodies; MW 12.2k >98% (SDS-PAGE) & HPLC; <0.1 ng endotoxin per Schmid, K etal, Biochemistry, 12:2711, 1973 mg (1EU/mg); lyophilized | In the CC chemokine family; similar to Scipac P153-0 Orosomucoid, from serum/plasma >99%; Exodus-1 (aka MIP-3α & LARC); inhibits hemopoiesis & stimulating lyophilized | Acute phase serum protein chemotaxis; 111 AA; SA determined by its ability to chemoattract total lymphocyte population Scipac P153-1 Orosomucoid, from serum/plasma >96%; lyophilized | Acute phase serum protein Sigma C 0720 Human recombinant, expressed in E. coli Lyophilized from 30% acetonitrile/0.1% TFA containing 1.25 BSA Scipac P153-2 Serum/plasma 40-90%; lyophilized | Serum protein Biogenesis 4396-0350 Mouse r-DNA Lyophilized Sigma C 0845 Mouse recombinant, expressed in E. coli Lyophilized from 30% acetonitrile/0.1% TFA containing 1.25 BSA | Actibind K Endotoxin tested; cell culture tested; long-term growth & ICN 797091/797092 Streptococcus Protein from a variant metabolism of most mammalian cells in culture require that growth of Streptococcal protein L that binds κ light chains &/or the Fab factors, hormones & other factors be present in the basal medium; portion of immunoglobulins of all types; useful in the purification of these factors are provided by fetal bovine serum &/or other sera monoclonal Ab & F Ab fragments routinely used in cell culture protocols; endotoxin tested; cell ab culture tested PeproTech 250-13 Murine recombinant, expressed in E. coli Actin MW 12.0k >98% (SDS-PAGE) & HPLC; <0.1 ng endotoxin per ICN 771012 MW 43k Purified | Suitable for use as a high mg (1EU/mg); lyophilized | In the CC chemokine family; similar to MW marker or as a standard; may be used as an antigen for Ab Exodus-1 (MIP-3a/LARC); inhibits hemopoiesis & stimulating development chemotaxis 110 AA; SA determined by its ability to chemoattract Fluka 01813 Bovine muscle ≥90% (gel electrophoresis); total murine T cell population ≥99% protein; white powder Cortex CP1110 Rabbit >95% Abrin Toxin A Biodesign A08001R Rabbit muscle Purified Sigma L 2017 Abrus precatorius (Jequirity bean) Highly Biogenesis 0070-2504 Rabbit muscle MW 46k Purified; purified by affinity & ion exchange chromatography; solution in 50% glycerol; liquid | Stimulates myosin ATPase activity if first 0.01 M potassium phosphate, pH 7.2, containing 0.15 M NaCl & polymerized 0.1% sodium azide; activity: >50 µg/mL (the lowest concentration Fluka 01812 Rabbit muscle MW ~43k ~96% (gel to agglutinate a 2% suspension of human erythrocytes after 1 hr at electrophoresis) | One of the major proteins of muscle & an 25°C) | Lectin important component of all eukaryotic cells; useful as a reference standard for SDS-PAGE & 2D-electrophoresis; role in muscle Abrin Toxin A & C contraction & relaxation, also involved in a variety of cellular events: cell movement, cytokinesis, chromosome movement, Sigma L 9633 Abrus precatorius (Jequirity bean) Highly phagocytosis & exocytosis; Pudich, J, Watt, S, JBC, 246: 4866, purified by affinity chromatography according to the method of 1971; Vandekerckhove, J & Weber, K, Eur J Biochem, 90: 451, Wei, CH et al, J Biol Chem, 249: 3061, 1974; solution in 0.01 M 1978; Korn, ED, Physiol Rev, 62: 672, 1982; Korn, ED, PNAS, 75: potassium phosphate, pH 7.2, containing 0.15 M NaCl & 0.1% 588, 1978 sodium azide; activity: <60 µg/mL (the lowest concentration to µ µ agglutinate a 2% suspension of human erythrocytes after 1 hr at ICN 159848 Rabbit muscle 3 g/g inhibits 1 g of DNAse I; 25°C) | Lectin >90% | Prepared by a slightly different procedure (reference below); can be used in cell transport & motion studies; inhibits DNAse I & possibly controls DNAse I nucleolytic activity during the Abrin Toxin C cell cycle; Spudich, JA & S Watt, J Biol Chem, 246:4866, 1971 Sigma L 1892 Abrus precatorius (Jequirity bean) Highly purified by affinity & ion exchange chromatography; solution in Actinin 0.01 M potassium phosphate, pH 7.2, containing 0.15 M NaCl & 0.1% sodium azide; activity: <60 µg/mL (the lowest concentration Biodesign A08002C Chicken gizzard Purified to agglutinate a 2% suspension of human erythrocytes after 1 hr at 25°C) | Lectin; this is a further purification of Sigma L 9633 to Actinin, α- eliminate the abrin A content Sigma A 9776 Chicken Gizzard MW ~100k ~80% (SDS- PAGE); suspension in 2 M (NH4)2SO4 containing 20 mM Tris Acetylcholine Transporter Protein acetate, pH 7.6, 20 mM sodium chloride, 0.1 mM EDTA, 15 mM β- Biotrend 0030-5059 Rat, synthetic >80% | Antigen mercaptoethanol & 1 mM phenylmethylsulfonyl fluoride | Prepared using a modification of the procedure of Neidel, JE & Cuatrecasas, P, Biochem Biophys Res Commun, 91: 152, 1979 6 User's Guide pp. 1-2, Glossary/Indexes pp. 963-1063 Proteins Actinomycin C Aequorin Synonyms: Actinomycin C1; Actinomycin C2; Actinomycin C3 ICN 194084 Jellyfish (Aequorea sp.) Purified powder | A Sigma A 4639 Streptomyces chrysomallus ~95% (HPLC) | bioluminescent protein used in immunoassay procedures; reported to measure calcium serum & subcellular organelle levels <10 µM; Mixture of actinomycins C1, C2, & C3 Izutsu, KT & SP Felton, Clin Chem, 18:77, 1972 Actinomycin D Aequorin Type III Synonyms: Actinomycin IV; Actinomycin C1 Sigma A 4140 Aequorea species (jellyfish) ~0.5% protein Sigma A 1410 Streptomyces species FW 1255.4 ~98% (HPLC); | Protein antibiotic that inhibits cell proliferation by (Bradford) in buffer salts consisting mainly of sodium EDTA, pH 7.5 | A bioluminescent protein; used to measure physiological levels of forming a stable complex with double-stranded DNA & inhibiting µ RNA synthesis calcium in serum & subcellular organelles down to 10 M; 1 mg solid will yield ~200 calcium assays; Izutsu, KT & Felton, SP, Clin Sigma A 4262 Streptomyces species FW 1255.4 ~95% Chem, 18: 77 (1972); Azzi, A & Chance, B, Biochim Biophys Acta, (HPLC); 189: 141 (1969) Actinomycin D, Mannitol 3 Aflatoxin B1, ( H(G))- Sigma A 5156 Lyophilized powder; each vial contains 1 mg ARC ART-247 MW 312.3 15-30 Ci/mmol; 0.55-1.11 actinomycin D & 49 mg of mannitol | Soluble at 20 mg/mL in TBq/mmol; in methanol | Radiochemical water Aflatoxin B , (8,9-3H)- Actinomycin I 2 ARC ART-617 MW 314.3 20-50 Ci/mmol; 0.74-1.85 Sigma A 3012 Streptomyces antibioticus FW 1263.5 TBq/mmol; in methanol | Radiochemical ~80% (HPLC) Aflatoxin M , (3H(G))- Actinomycin V 1 ARC ART-616 MW 328.3 1-5 Ci/mmol; 37-185 GBq/mmol; in Sigma A 2887 Streptomyces antibioticus FW 1269.4 methanol | Radiochemical ~95% (HPLC) Agglutinin, Abrus precatorius Activin A Synonyms: Abrin; Lectin Sigma A 4839 Bovine recombinant, expressed in E. coli Lyophilized from 40% acetonitrile/0.1% TFA | Endotoxin tested; Sigma L 9758 Abrus precatorius (Jequirity bean) Highly cell culture tested; see Sigma C 0720 purified by affinity chromatography according to the method of Lin, J-Y et al, Toxicon, 19: 41, 1981; solution in 0.01 M potassium phosphate, pH 7.2, containing 0.15 M NaCl & 0.1% sodium azide; Acyl Carrier Protein activity: <2 µg/mL (the lowest concentration to agglutinate a 2% ° Sigma A 7303 Escherichia coli ≥60% pure by electrophoresis suspension of human erythrocytes after 1 hr at 25 C) | Extremely in 1% 2-β-MSH; lyophilized hazardous! Be aware of the risks & familiar with safety procedures before you ruse this product; not blood group specific but has an affinity for D-galactose; seeds of Abrus precatorius contain a Adenovirus Type VI nontoxic agglutinin together with 2 major toxic proteins, Abrin A2 2 USBio A0880-02 Single peak by HPLC; 5 mg/mL protein; in also referred to as Abrin b+c & Abrin C also referred to as Abrin a; MEM buffer | Suitable for antigenic applications in immunological conjugates are prepared from affinity purified lectin; activity is µ protocols expressed in g/mL & is determined from serial dilutions in phosphate buffered saline, pH 7.2 of a 1 mg/mL solution; Tomita, M et al, Experientia, 28: 84, 1972; Wei, CH et al, J Biol Chem, 249: Adenylate Cyclase Toxin 3061, 1974; Lin, J-Y et al, Toxicon, 19: 41, 1981; Olsnes, S et al, J Alexis 630-088 Bordetella pertussis recombinant, expressed in Biol Chem, 249: 803, 1974 E. coli MW ~177k ≥90%; lyophilized powder; soluble in water; reconstitute in
Load more

Recommended publications
  • Chemical Disinfectants for Biohazardous Materials (3/21)
    Safe Operating Procedure (Revised 3/21) CHEMICAL DISINFECTANTS FOR BIOHAZARDOUS MATERIALS ____________________________________________________________________________ Chemicals used for biohazardous decontamination are called sterilizers, disinfectants, sanitizers, antiseptics and germicides. These terms are sometimes equivalent, but not always, but for the purposes of this document all the chemicals described herein are disinfectants. The efficacy of every disinfectant is based on several factors: 1) organic load (the amount of dirt and other contaminants on the surface), 2) microbial load, 3) type of organism, 4) condition of surfaces to be disinfected (i.e., porous or nonporous), and 5) disinfectant concentration, pH, temperature, contact time and environmental humidity. These factors determine if the disinfectant is considered a high, intermediate or low-level disinfectant, in that order. Prior to selecting a specific disinfectant, consider the relative resistance of microorganisms. The following table provides information regarding chemical disinfectant resistance of various biological agents. Microbial Resistance to Chemical Disinfectants: Type of Microbe Examples Resistant Bovine spongiform encephalopathy (Mad Prions Cow) Creutzfeldt-Jakob disease Bacillus subtilis; Clostridium sporogenes, Bacterial Spores Clostridioides difficile Mycobacterium bovis, M. terrae, and other Mycobacteria Nontuberculous mycobacterium Poliovirus; Coxsackievirus; Rhinovirus; Non-enveloped or Small Viruses Adenovirus Trichophyton spp.; Cryptococcus sp.;
    [Show full text]
  • Chemical Threat Agents Call Poison Control 24/7 for Treatment Information 1.800.222.1222 Blood Nerve Blister Pulmonary Metals Toxins
    CHEMICAL THREAT AGENTS CALL POISON CONTROL 24/7 FOR TREATMENT INFORMATION 1.800.222.1222 BLOOD NERVE BLISTER PULMONARY METALS TOXINS SYMPTOMS SYMPTOMS SYMPTOMS SYMPTOMS SYMPTOMS SYMPTOMS • Vertigo • Diarrhea, diaphoresis • Itching • Upper respiratory tract • Cough • Shock • Tachycardia • Urination • Erythema irritation • Metallic taste • Organ failure • Tachypnea • Miosis • Yellowish blisters • Rhinitis • CNS effects • Cyanosis • Bradycardia, bronchospasm • Flu-like symptoms • Coughing • Shortness of breath • Flu-like symptoms • Emesis • Delayed eye irritation • Choking • Flu-like symptoms • Nonspecific neurological • Lacrimation • Delayed pulmonary edema • Visual disturbances symptoms • Salivation, sweating INDICATIVE LAB TESTS INDICATIVE LAB TESTS INDICATIVE LAB TEST INDICATIVE LAB TESTS INDICATIVE LAB TESTS INDICATIVE LAB TESTS • Increased anion gap • Decreased cholinesterase • Thiodiglycol present in urine • Decreased pO2 • Proteinuria None Available • Metabolic acidosis • Increased anion gap • Decreased pCO2 • Renal assessment • Narrow pO2 difference • Metabolic acidosis • Arterial blood gas between arterial and venous • Chest radiography samples DEFINITIVE TEST DEFINITIVE TEST DEFINITIVE TEST DEFINITIVE TESTS DEFINITIVE TESTS • Blood cyanide levels • Urine nerve agent • Urine blister agent No definitive tests available • Blood metals panel • Urine ricinine metabolites metabolites • Urine metals panel • Urine abrine POTENTIAL AGENTS POTENTIAL AGENTS POTENTIAL AGENTS POTENTIAL AGENTS POTENTIAL AGENTS POTENTIAL AGENTS • Hydrogen Cyanide
    [Show full text]
  • Irina Nicoleta Cimalla Algan/Gan Sensors for Direct Monitoring Of
    Irina Nicoleta Cimalla AlGaN/GaN sensors for direct monitoring of fluids and bioreactions AlGaN/GaN sensors for direct monitoring of fluids and bioreactions Irina Nicoleta Cimalla Universitätsverlag Ilmenau 2011 Impressum Bibliografische Information der Deutschen Nationalbibliothek Die Deutsche Nationalbibliothek verzeichnet diese Publikation in der Deutschen Nationalbibliografie; detaillierte bibliografische Angaben sind im Internet über http://dnb.d-nb.de abrufbar. Diese Arbeit hat der Fakultät für Elektrotechnik und Informationstechnik der Technischen Universität Ilmenau als Dissertation vorgelegen. Tag der Einreichung: 23. November 2009 1. Gutachter: PD Dr. rer. nat. habil. Andreas Schober (Technische Universität Ilmenau) 2. Gutachter: Univ.-Prof. Dr. rer. nat. habil. Oliver Ambacher (Fraunhofer Institut für Angewandte Festkörperphysik Freiburg) 3. Gutachter: PD Dr.-Ing. habil. Frank Schwierz (Technische Universität Ilmenau) Tag der Verteidigung: 15. Juli 2010 Technische Universität Ilmenau/Universitätsbibliothek Universitätsverlag Ilmenau Postfach 10 05 65 98684 Ilmenau www.tu-ilmenau.de/universitaetsverlag Herstellung und Auslieferung Verlagshaus Monsenstein und Vannerdat OHG Am Hawerkamp 31 48155 Münster www.mv-verlag.de ISBN 978-3-86360-003-7 (Druckausgabe) URN urn:nbn:de:gbv:ilm1-2010000519 Titelfoto: photocase.com | AlexFlint „Unde dragoste nu e, nimic nu e” „Wo Liebe nicht ist, ist gar nichts“ Marin Preda: „Cel mai iubit dintre pamanteni“ 5 6 Abstract In this thesis, AlGaN/GaN heterostructures, which have shown to be reliable pH sensors, have been characterized and further developed for the in situ monitoring of cell reactions. For this reason, NG108-15 nerve cells were cultivated on sensor surfaces and their response on different neuroinhibitors was clearly monitored. First, a measurement setup for extracellular recording was designed in connection with an improved chip design and sensor technology.
    [Show full text]
  • Small Molecule Modulators Reveal Mechanisms Regulating Cell Death
    Investigating neurodegenerative diseases with small molecule modulators Reka Rebecca Letso Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2011 ©2011 Reka Rebecca Letso All Rights Reserved Abstract Investigating neurodegenerative diseases with small molecule modulators Reka Rebecca Letso Elucidation of the mechanisms underlying cell death in neurodegenerative diseases has proven difficult, due to the complex and interconnected architecture of the nervous system as well as the often pleiotropic nature of these diseases. Cell culture models of neurodegenerative diseases, although seldom recapitulating all aspects of the disease phenotype, enable investigation of specific aspects of these disease states. Small molecule screening in these cell culture models is a powerful method for identifying novel small molecule modulators of these disease phenotypes. Mechanistic studies of these modulators can reveal vital insights into the cellular pathways altered in these disease states, identifying new mechanisms leading to cellular dysfunction, as well as novel therapeutic targets to combat these destructive diseases. Small molecule modulators of protein activity have proven invaluable in the study of protein function and regulation. While inhibitors of protein activity are relatively common, small molecules that can increase protein abundance are quite rare. Small molecule protein upregulators with targeted activities would be of great value in the study of the mechanisms underlying many loss of function diseases. We developed a high- throughput screening approach to identify small molecule upregulators of the Survival of Motor Neuron protein (SMN), whose decreased levels cause the neurodegenerative disease Spinal Muscular Atrophy (SMA). We screened 69,189 compounds for SMN upregulators and performed mechanistic studies on the most active compound, a bromobenzophenone analog designated cuspin-1.
    [Show full text]
  • Families and the Structural Relatedness Among Globular Proteins
    Protein Science (1993), 2, 884-899. Cambridge University Press. Printed in the USA. Copyright 0 1993 The Protein Society -~~ ~~~~ ~ Families and the structural relatedness among globular proteins DAVID P. YEE AND KEN A. DILL Department of Pharmaceutical Chemistry, University of California, San Francisco, California94143-1204 (RECEIVEDJanuary 6, 1993; REVISEDMANUSCRIPT RECEIVED February 18, 1993) Abstract Protein structures come in families. Are families “closely knit” or “loosely knit” entities? We describe a mea- sure of relatedness among polymer conformations. Based on weighted distance maps, this measure differs from existing measures mainly in two respects: (1) it is computationally fast, and (2) it can compare any two proteins, regardless of their relative chain lengths or degree of similarity. It does not require finding relative alignments. The measure is used here to determine the dissimilarities between all 12,403 possible pairs of 158 diverse protein structures from the Brookhaven Protein Data Bank (PDB). Combined with minimal spanning trees and hier- archical clustering methods,this measure is used to define structural families. It is also useful for rapidly searching a dataset of protein structures for specific substructural motifs.By using an analogy to distributions of Euclid- ean distances, we find that protein families are not tightly knit entities. Keywords: protein family; relatedness; structural comparison; substructure searches Pioneering work over the past 20 years has shown that positions after superposition. RMS is a useful distance proteins fall into families of related structures (Levitt & metric for comparingstructures that arenearly identical: Chothia, 1976; Richardson, 1981; Richardson & Richard- for example, when refining or comparing structures ob- son, 1989; Chothia & Finkelstein, 1990).
    [Show full text]
  • Molecular Mechanisms of Neuroimmune Crosstalk in the Pathogenesis of Stroke
    International Journal of Molecular Sciences Review Molecular Mechanisms of Neuroimmune Crosstalk in the Pathogenesis of Stroke Yun Hwa Choi 1, Collin Laaker 2, Martin Hsu 2, Peter Cismaru 3, Matyas Sandor 4 and Zsuzsanna Fabry 2,4,* 1 School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA; [email protected] 2 Neuroscience Training Program, University of Wisconsin-Madison, Madison, WI 53705, USA; [email protected] (C.L.); [email protected] (M.H.) 3 Chemistry, University of Wisconsin-Madison, Madison, WI 53705, USA; [email protected] 4 Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA; [email protected] * Correspondence: [email protected] Abstract: Stroke disrupts the homeostatic balance within the brain and is associated with a significant accumulation of necrotic cellular debris, fluid, and peripheral immune cells in the central nervous system (CNS). Additionally, cells, antigens, and other factors exit the brain into the periphery via damaged blood–brain barrier cells, glymphatic transport mechanisms, and lymphatic vessels, which dramatically influence the systemic immune response and lead to complex neuroimmune communi- cation. As a result, the immunological response after stroke is a highly dynamic event that involves communication between multiple organ systems and cell types, with significant consequences on not only the initial stroke tissue injury but long-term recovery in the CNS. In this review, we discuss the complex immunological and physiological interactions that occur after stroke with a focus on how the peripheral immune system and CNS communicate to regulate post-stroke brain homeostasis. First, Citation: Choi, Y.H.; Laaker, C.; Hsu, we discuss the post-stroke immune cascade across different contexts as well as homeostatic regulation M.; Cismaru, P.; Sandor, M.; Fabry, Z.
    [Show full text]
  • B1–Proteases As Molecular Targets of Drug Development
    Abstracts B1–Proteases as Molecular Targets of Drug Development B1-001 lin release from the beta cells. Furthermore, GLP-1 also stimu- DPP-IV structure and inhibitor design lates beta cell growth and insulin biosynthesis, inhibits glucagon H. B. Rasmussen1, S. Branner1, N. Wagtmann3, J. R. Bjelke1 and secretion, reduces free fatty acids and delays gastric emptying. A. B. Kanstrup2 GLP-1 has therefore been suggested as a potentially new treat- 1Protein Engineering, Novo Nordisk A/S, Bagsvaerd, Denmark, ment for type 2 diabetes. However, GLP-1 is very rapidly degra- 2Medicinal Chemistry, Novo Nordisk A/S, Maaloev, Denmark, ded in the bloodstream by the enzyme dipeptidyl peptidase IV 3Discovery Biology, Novo Nordisk A/S, Maaloev, DENMARK. (DPP-IV; EC 3.4.14.5). A very promising approach to harvest E-mail: [email protected] the beneficial effect of GLP-1 in the treatment of diabetes is to inhibit the DPP-IV enzyme, thereby enhancing the levels of The incretin hormones GLP-1 and GIP are released from the gut endogenously intact circulating GLP-1. The three dimensional during meals, and serve as enhancers of glucose stimulated insu- structure of human DPP-IV in complex with various inhibitors 138 Abstracts creates a better understanding of the specificity and selectivity of drug-like transition-state inhibitors but can be utilized for the this enzyme and allows for further exploration and design of new design of non-transition-state inhibitors that compete for sub- therapeutic inhibitors. The majority of the currently known DPP- strate binding. Besides carrying out proteolytic activity, the IV inhibitors consist of an alpha amino acid pyrrolidine core, to ectodomain of memapsin 2 also interacts with APP leading to which substituents have been added to optimize affinity, potency, the endocytosis of both proteins into the endosomes where APP enzyme selectivity, oral bioavailability, and duration of action.
    [Show full text]
  • 2018 Annual Survey of Biological and Chemical Agents Regulated by Homeland Security (And Carcinogens Regulated by OSHA)
    Name: Dept: Date: 2018 Annual Survey of Biological and Chemical Agents regulated by Homeland Security (and carcinogens regulated by OSHA) Due (date) All labs that do not have a current chemical inventory in Chematix MUST complete this survey. The University is required to make an annual report of all chemicals on the Chemical Facility Anti-Terrorism Standards (CFATS) lists. Additional information regarding the regulations is available on the EH&S website at http://www.safety.rochester.edu/restricted/occsafe/chemicalagent.html and https://www.selectagents.gov. 1. Please review the lists on the following pages and indicate if any are possessed by your lab. The CAS# has been added to the list for ease of searching databases. The CAS# is a Chemical Abstract Service numbering system which assigns a unique number to every chemical substance based on structure; this helps avoid confusion by use of synonyms or different naming conventions. a. If yes for possession, place an X in the applicable box and if requested, include the quantity held in your lab. b. If no, leave blank. 2. After reviewing the list, please complete the information box below (or on last page for possession), then sign, date and return to EH&S. 3. Please call Donna Douglass at 275-2402 if you have any questions. Thank you for your cooperation in collecting data required by the Department of Homeland Security! Possession: 1) Fill in applicable boxes, 2) have PI sign last page, 3) return all pages to Donna Douglass OR Non-possession: 1) Check only one box on the left, 2) sign, 3) return just this page to Donna Douglass I do not have a lab, do not work in a lab, nor do I possess any of the agents in this survey.
    [Show full text]
  • Protein Kinase C Activates an H' (Equivalent) Conductance in The
    Proc. Nati. Acad. Sci. USA Vol. 88, pp. 10816-10820, December 1991 Cell Biology Protein kinase C activates an H' (equivalent) conductance in the plasma membrane of human neutrophils (HI channels/pH regulation/leukocytes/H+-ATPase/bafllomycin) ARVIND NANDA AND SERGIO GRINSTEIN* Division of Cell Biology, Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada Communicated by Edward A. Adelberg, August 12, 1991 ABSTRACT The rate of metabolic acid generation by it can be calculated that pH1 would be expected to drop by neutrophils increases greatly when they are activated. Intra- over 5 units (to pH 1.6) if the metabolically generated H+ cellular acidification is prevented in part by Na+/H' ex- were to remain within the cell. However, cells stimulated in change, but a sizable component ofH+ extrusion persists in the the nominal absence of Na+ and HCO- maintain their pH1 nominal absence of Na' and HCO3 . In this report we deter- above 6.4, suggesting that alternative (Na+- and HCO3- mined the contribution to H+ extrusion of a putative HI independent) H+ extrusion mechanisms must exist in acti- conductive pathway and its mode ofactivation. In unstimulated vated neutrophils. Accordingly, accelerated extracellular cells, H+ conductance was found to be low and unaffected by acidification can be recorded under these conditions. depolarization. An experimental system was designed to min- The existence of H+-conducting channels has been docu- imize the metabolic acid generation and membrane potential mented in snail neurones (5) and axolotl oocytes (6). In these changes associated with neutrophil activation. By using this tissues, the channels are inactive at the resting plasma system, (3-phorbol esters were shown to increase the H+ membrane potential (Em) but open when the membrane (equivalent) permeability of the plasma membrane.
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2008/0026032 A1 ZUBERY Et Al
    US 2008.0026.032A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2008/0026032 A1 ZUBERY et al. (43) Pub. Date: Jan. 31, 2008 (54) COMPOSITE IMPLANTS FOR PROMOTING Publication Classification BONE REGENERATION AND (51) Int. Cl. AUGMENTATION AND METHODS FOR A6F 2/00 (2006.01) THER PREPARATION AND USE A638/00 (2006.01) A6IP 9/00 (2006.01) (76) Inventors: Yuval ZUBERY, Cochav Yair (52) U.S. Cl. ............................................ 424/423: 514/2 (IL); Arie Goldlust, Ness Ziona (57) ABSTRACT (IL); Thomas Bayer, Tel-Aviv (IL); Eran Nir, Rehovot (IL) Collagen based matrices cross-linked by a reducing Sugar(s) are used for preparing composite matrices, implants and scaffolds. The composite matrices may have at least two Correspondence Address: layers including reducing Sugar cross-linked collagen matri DANEL, SWIRSKY ces of different densities. The composite matrices may be 55 REUVEN ST. used in bone regeneration and/or augmentation applications. BET SHEMESH 99.544 Scaffolds including glycated and/or reducing Sugar cross linked collagen exhibit improved support for cell prolifera (21) Appl. No.: 11/829,111 tion and/or growth and/or differentiation. The denser col lagen matrix of the composite matrices may have a dual effect initially functioning as a cell barrier and later func (22) Filed: Jul. 27, 2007 tioning as an ossification Supporting layer. The composite matrices, implants and scaffolds may be prepared using different collagen types and collagen mixtures and by cross Related U.S. Application Data linking the collagen(s) using a reducing Sugar or a mixture (60) Provisional application No. 60/833,476, filed on Jul.
    [Show full text]
  • Autophagy Flux in Critical Illness, a Translational Approach
    www.nature.com/scientificreports OPEN Autophagy fux in critical illness, a translational approach Nicolas Tardif 1,2, Franck Polia2, Inga Tjäder1,2, Thomas Gustafsson3 & Olav Rooyackers1,2 Recent clinical trials suggest that early nutritional support might block the induction of autophagy in Received: 17 October 2018 critically ill patients leading to the development of organ failure. However, the regulation of autophagy, Accepted: 7 June 2019 especially by nutrients, in critical illness is largely unclear. The autophagy fux (AF) in relation to critical Published: xx xx xxxx illness and nutrition was investigated by using an in vitro model of human primary myotubes incubated with serum from critically ill patients (ICU). AF was calculated as the diference of p62 expression in the presence and absence of chloroquine (50 µM, 6 h), in primary myotubes incubated for 24 h with serum from healthy volunteers (n = 10) and ICU patients (n = 93). We observed 3 diferent phenotypes in AF, non-altered (ICU non-responder group), increased (ICU inducer group) or blocked (ICU blocker group). This block was not associate with a change in amino acids serum levels and was located at the accumulation of autophagosomes. The increase in the AF was associated with lower serum levels of non-essential amino acids. Thus, early nutrition during critical illness might not block autophagy but could attenuate the benefcial efect of starvation on reactivation of the autophagy process. This could be of clinical importance in the individual patients in whom this process is inhibited by the critical illness insult. Critically ill patients treated in an Intensive Care Unit (ICU) ofen have organ failure already at their admittance or will develop it early during their stay in the unit.
    [Show full text]